Health & Fitness
Health and Fitness
Health and Fitness 
Wed, September 15, 2010
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
[ Wed, Sep 15th 2010
] - Market Wire
Tue, September 14, 2010
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
[ Tue, Sep 14th 2010
] - Market Wire
El tratamiento VIH de nico comprimido "Quad" de Gilead consigue alta supresin viral durante 48 semanas en estudio de fase II
FOSTER CITY, California--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) ha comunicado los resultados del ensayo clnico de fase II que revelan que su tratamiento en fase de investigacin, de dosis fija y nico comprimido, "Quad" de elvitegravir, cobicistat y Truvada® (emtricitabina y fumarato de tenofovir disoproxil) para el tratamiento de infecciones VIH ha conseguido una tasa alta de supresin virolgica durante 48 semanas, demostrando una actividad antirretroviral comparable a la de Atripla® (efavirenz 600 mg/emtricitabina 200 mg/ fumarato de tenofovir disoproxil 300 mg).
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.